Diabetes drug shows promise in reducing risk of cancer

	Tweet

An inexpensive drug that treats Type-2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study by a Michigan State University researcher.

The research, led by pediatrics professor James Trosko and colleagues from South Korea’s Seoul National University, provides biological evidence for previously reported epidemiological surveys that long-term use of the drug metformin for Type-2 diabetes reduces the risk of diabetes-associated cancers, such as breast cancers.

The research appears in the current edition of PLoS One.

“People with Type-2 diabetes are known to be at high risk for several diabetes-associated cancers, such as breast, liver and pancreatic cancers,” said Trosko, a professor in the College of Human Medicine’s Department of Pediatrics and Human Development. “While metformin has been shown in population studies to reduce the risk of these cancers, there was no evidence of how it worked.”

For the study, Trosko and colleagues focused on the concept that cancers originate from adult human stem cells and that there are many natural and man-made chemicals that enhance the growth of breast cancer cells.

Using culture dishes, they grew miniature human breast tumors, or mammospheres, that activated a certain stem cell gene (Oct4A). Then the mammospheres were exposed to natural estrogen – a known growth factor and potential breast tumor promoter – and man-made chemicals that are known to promote tumors or disrupt the endocrine system.

The team found that estrogen and the chemicals caused the mammospheres to increase in numbers and size. However, with metformin added, the numbers and size of the mammospheres were dramatically reduced. While each of the chemicals enhanced growth by different means, metformin seemed to be able to inhibit their stimulated growth in all cases.

“While future studies are needed to understand the exact mechanism by which metformin works to reduce the growth of breast cancers, this study reveals the need to determine if the drug might be used as a preventive drug and for individuals who have no indication of any existing cancers,” he said.

“Though we still do not know the exact molecular mechanism by which it works, metformin seems to dramatically affect how estrogen and endocrine-disrupting chemicals cause the pre-existing breast cancers to grow.”

In addition, further research needs to be done with human cultures to see if metformin can reduce the risk of pancreatic and liver cancers in Type-2 diabetics as well, he said.

###

Michigan State University has been working to advance the common good in uncommon ways for more than 150 years. One of the top research universities in the world, MSU focuses its vast resources on creating solutions to some of the world’s most pressing challenges, while providing life-changing opportunities to a diverse and inclusive academic community through more than 200 programs of study in 17 degree-granting colleges.

###

Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University

RELATED STORIES:
Yoga improves quality of life in women with breast cancer undergoing radiation therapy   Ultrasound-guided surgery is best way to remove breast tumours   Sisters of women with breast cancer joining study   Researchers identify new protein that triggers breast cancer   Metastasis-Promoting Protein Identified; Could Provide a Prognostic Test Or Target for Breast Cancer   Exercise after age 30 may curb breast cancer risk   Combination therapy shows improvement for breast cancer patients   Liposuction: A source for breast augmentation?   Healthy habits prevent breast cancer: study   Breast Cancer Statistics   Targeted magnetic nanoparticles may be useful in detecting and treating metastatic breast cancers   Racial and ethnic differences in the biology of breast cancer tumors   US panel mulls minimum breast cancer hospital stay   FDA Approves Test for HER2 Gene in Breast Cancer Tissue   Large study documents how p53 mutations link to high-grade breast cancer, poor outcomes   Survival in metastatic breast cancer patients is improving: targeted therapies have contributed   Fox Chase scientists identify key protein players in hard-to-treat breast cancers   Study Questions True Favorability of Rare Breast Cancer Type   8 Natural Ways to Prevent Breast Cancer   Emerging research heralds new era of breast cancer management   Celldex breast cancer drug shrinks some tumors: study   Error rate higher in breast imaging reports generated by automatic speech recognition

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]